PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Metersky, Mark L.
TI  - Improving Outcomes of Ventilator-Associated Pneumonia
DP  - 2013 Aug 01
TA  - MD Conference Express
PG  - 26--27
VI  - 13
IP  - 4
4099  - http://mdc.sagepub.com/content/13/4/26.short
4100  - http://mdc.sagepub.com/content/13/4/26.full
AB  - Nosocomial pneumonia, especially ventilator-associated pneumonia (VAP), is a major cause of morbidity and mortality in the intensive care unit (ICU). This article discusses updates on bacterial resistance relevant to VAP, with a focus on methicillin-resistant Staphylococcus aureus (MRSA), treating MRSA pneumonia in the ICU, the use of tigecycline and doripenem for hospital-acquired pneumonia and VAP, and the potential utility of inhaled antibiotics as an alternative in the treatment of patients with VAP.